Literature DB >> 16205926

Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Salih Pay1, Hakan Erdem, Aysel Pekel, Ismail Simsek, Ugur Musabak, Ali Sengul, Ayhan Dinc.   

Abstract

The objective of this study has been the well established fact that proinflammatory cytokines and metalloproteinases play a crucial role in the pathogenesis of chronic arthritis as well as the development of pannus, with the eventual erosive changes. Among the proinflammatory cytokines, interleukin-18 (IL-18) has been shown to contribute to the pathogenesis of chronic synovitis by increasing the secretion of interleukin-1beta (IL-1beta) and the tumor necrosis factor-alpha (TNF-alpha) and also stimulating angiogenesis. The aim of this study is to investigate the synovial IL-18, IL-1beta, TNF-alpha and matrix metalloproteinase-3 (MMP-3) levels in patients with Behçet's disease (BD), and compare them with the levels of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). 30 patients with BD, 20 with RA, and 20 with OA were included in the study. The synovial levels of IL-18, IL-1beta, TNF-alpha and MMP-3 were detected using the two-step sandwich ELISA method. The synovial IL-18, TNF-alpha and MMP-3 levels were significantly higher in RA patients than patients with BD (P=0.004, 0.019, 0.025, respectively) and with OA (P=0.004, 0.045, 0.032, respectively). There were no differences, with respect to the cytokine levels, when patients with BD were compared with those with OA. Patients with RA and BD had higher IL-1beta levels than patients with OA (P=0.017, 0.013, respectively). However, no such difference was found for IL-1beta between BD and RA patients. Among patients with RA, positive correlations were found between TNF-alpha and MMP-3 (r=0.683, P=0.001). Our results showed that MMP-3 and proinflammatory cytokines, except IL-1beta, were expressed in relatively small quantities in Behçet's synovitis. Detection of the lower levels of these cytokines and metalloproteinases might explain the non-erosive character of Behçet's arthritis. We suggest that IL-1beta may be involved in the pathogenesis of Behçet's synovitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205926     DOI: 10.1007/s00296-005-0040-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

1.  A role for IL-18 in neutrophil activation.

Authors:  B P Leung; S Culshaw; J A Gracie; D Hunter; C A Canetti; C Campbell; F Cunha; F Y Liew; I B McInnes
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

Review 2.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways.

Authors:  J C Morel; C C Park; J M Woods; A E Koch
Journal:  J Biol Chem       Date:  2001-07-27       Impact factor: 5.157

4.  Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment.

Authors:  C Ribbens; M Martin y Porras; N Franchimont; M-J Kaiser; J-M Jaspar; P Damas; F A Houssiau; M G Malaise
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

5.  Significant increases in serum and plasma concentrations of matrix metalloproteinases 3 and 9 in patients with rapidly destructive osteoarthritis of the hip.

Authors:  Kensaku Masuhara; Tsuyoshi Nakai; Katsuyuki Yamaguchi; Satoshi Yamasaki; Yasuyuki Sasaguri
Journal:  Arthritis Rheum       Date:  2002-10

6.  Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis.

Authors:  A I Catrina; J Lampa; S Ernestam; E af Klint; J Bratt; L Klareskog; A-K Ulfgren
Journal:  Rheumatology (Oxford)       Date:  2002-05       Impact factor: 7.580

7.  Relation between interleukin-18 and PGE2 in synovial fluid of osteoarthritis: a potential therapeutic target of cartilage degradation.

Authors:  Hiroyuki Futani; Akira Okayama; Kiyoshi Matsui; Shinichiro Kashiwamura; Takashi Sasaki; Toshikazu Hada; Kenji Nakanishi; Hiroomi Tateishi; Soji Maruo; Haruki Okamura
Journal:  J Immunother       Date:  2002 Mar-Apr       Impact factor: 4.456

8.  Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

Authors:  Leo A B Joosten; Timothy R D Radstake; Erik Lubberts; Liduine A M van den Bersselaar; Piet L C M van Riel; Peter L E M van Lent; Pilar Barrera; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2003-02

9.  MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis.

Authors:  I Tchetverikov; H K Ronday; B Van El; G H Kiers; N Verzijl; J M TeKoppele; T W J Huizinga; J DeGroot; R Hanemaaijer
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

10.  Effect of repeated infliximab therapy on serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with rheumatoid arthritis.

Authors:  Piotr Adrian Klimiuk; Stanislaw Sierakowski; Izabela Domyslawska; Justyna Chwiecko
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

View more
  20 in total

Review 1.  Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Authors:  Jurgen Sota; Donato Rigante; Giuseppe Lopalco; Bruno Frediani; Rossella Franceschini; Mauro Galeazzi; Florenzo Iannone; Gian Marco Tosi; Claudia Fabiani; Luca Cantarini
Journal:  Rheumatol Int       Date:  2017-07-27       Impact factor: 2.631

2.  Serum IL-33 level and IL-33 gene polymorphisms in Behçet's disease.

Authors:  Suleyman Serdar Koca; Murat Kara; Firat Deniz; Metin Ozgen; Caner Feyzi Demir; Nevin Ilhan; Ahmet Isik
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

Review 3.  Behçet's syndrome pathophysiology and potential therapeutic targets.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Mario Milco D'Elios; Lucia Ciucciarelli; Domenico Prisco; Lorenzo Emmi
Journal:  Intern Emerg Med       Date:  2014-01-12       Impact factor: 3.397

Review 4.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

5.  Ultrasonographic Measurement of the Femoral Cartilage Thickness in Patients with Behçet's Disease.

Authors:  I Batmaz; M Kara; T Tiftik; M Yildiz; R Çevik; L Özçakar
Journal:  West Indian Med J       Date:  2015-03-05       Impact factor: 0.171

Review 6.  Behçet syndrome: from pathogenesis to novel therapies.

Authors:  Gianluigi Mazzoccoli; Angela Matarangolo; Rosa Rubino; Michele Inglese; Angelo De Cata
Journal:  Clin Exp Med       Date:  2014-12-02       Impact factor: 3.984

7.  Synovial angiostatic non-ELR CXC chemokines in inflammatory arthritides: does CXCL4 designate chronicity of synovitis?

Authors:  Hakan Erdem; Salih Pay; Ugur Musabak; Ismail Simsek; Ayhan Dinc; Aysel Pekel; Ali Sengul
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 2.631

8.  Ultrasonographic assessment of femoral cartilage thickness in patients with and without uveitis in Behçet's disease.

Authors:  Emre Ata; Murat Kosem; Tugba Ozsoy-Unubol
Journal:  Rheumatol Int       Date:  2019-07-23       Impact factor: 2.631

9.  Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients.

Authors:  Jun Araya; Stephanie Cambier; Jennifer A Markovics; Paul Wolters; David Jablons; Arthur Hill; Walter Finkbeiner; Kirk Jones; V Courtney Broaddus; Dean Sheppard; Andrea Barzcak; Yuanyuan Xiao; David J Erle; Stephen L Nishimura
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  A functional variant of pre-miRNA-196a2 confers risk for Behcet's disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis.

Authors:  Jian Qi; Shengping Hou; Qi Zhang; Dan Liao; Lin Wei; Jing Fang; Yan Zhou; Aize Kijlstra; Peizeng Yang
Journal:  Hum Genet       Date:  2013-08-09       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.